Parasitic roundworms (nematodes) of humans, livestock and other animals cause diseases of major socio-economic importance globally. They have a major, long-term impact (directly and indirectly) on health.  Nematode parasites pose the greatest current threat to global agricultural productivity. In animals, these parasites can cause debilitating gut, lung or liver disorders which impacts negatively on animal health and welfare, therefore impairing global food security. The current financial losses caused by parasites to agriculture worldwide (domesticated animals and crops) have a major impact on farm profitability and exacerbate the global food shortage.

Methods available for the Control of parasitic worms currently relies almost exclusively on the use of drugs, a solution threatened by the global emergence of worm populations that are resistant to the drugs used to control them. Moreover, the use of such drugs poses major risks of residue problems in meat, milk and the environment.

This European company focuses on clinical stage development of highly cost effective biological APIs based on their recombinant technology platform.  The company also develops in-vitro diagnostics kits based on a unique pool of recombinantly expressed products.

They u se a different process to orthodox fermentation method with insects as micro bio-reactors, this lowers development and manufacturing costs from - $150m-$650m reduced to $2m-$3m, reduces commissioning time, provides high yields and can be used as a Multi product facility

The company is currently looking for a Chinese partner to co-operate in manufacture and/or sales of their patented nematodes vaccine

Co-operation models:
Licensing for local manufacture and sales
Import to China.

Expected countries (regions) for cooperation:
CHINA.

If you can match this technology offer please contact us quoting: REF:GL1008A-002-TO/Co-operation to Promote patented Livestock Namatodes Vaccine in China

Back